Quality Improvement Team

Slides:



Advertisements
Similar presentations
HIV/AIDS in Brazil at a glance 11th Advanced HIV Course 1 – 3 September 2013, Aix-en-Provence, France Ana Flor Hexel Cornely Clinical Hospital, Porto Alegre.
Advertisements

Ministry of Health National STD/AIDS Programme Universal Access to Antiretroviral Therapy: The Brazilian Experience.
WHO – HIV department | February 21, |1 | November 2012 Core slides.
MINNESOTAS HIV TREATMENT CASCADE. Introduction This slide set describes the continuum of HIV care in Minnesota. The slides rely on data from HIV/AIDS.
Personnel Management FCMAT 2006 Update Delia Ruiz, Executive Officer of Human Resources January 10, 2007.
Nassau University Medical Center IPRO CAUTI Prevention Initiative November 6, 2013 New York Hotel, NY.
The Execution and Management of a Complex Clinical Trial Elizabeth K. Walsh, RN ECTSS 2013 Conflicts of Interest Advisory Board for TAVR Administrators.
Exhibit ES-1. Summary Highlights: National and State-Level Estimates, Under-65 Population PeoplePercent of population Millions 2012 National 2012 Lowest.
November 2012 Core slides HIV/AIDS Epidemiology Health care response.
ACCESS PLACE P. A. Update 101 – 15 TH Street East Prince Albert, SK January 31, 2012.
April 25, Welcome (Rebecca Marshall) 2. Review minutes (March 7, 2012 Meeting)(Rebecca Marshall) 3. Accident reports(Rebecca Marshall) 4. Plan.
Quality Improvement Team Members
Improving Client Retention in Primary Care QI Project Review Title I Case Management HIV Quality Learning Network June 28, 2007.
1 HIVQUAL-US Funded by HRSA HIV/AIDS Bureau HIVQUAL-US In+Care Campaign, Developing Process Diagrams, and Tests of Change/PDSAs Nanette Brey Magnani, EdD,
Changes in Viral Load after Home-based HIV Testing and Counseling - Swaziland Naomi Bock 1, Ruth Emerson 2, Velephi Okello 3, Neena Philip 4, Deborah Donnell.
Developing Workflow Process Diagrams To Target Interventions Moderator: Mindy Golatt, RN, MPH, Public Health Analyst, HRSA/HAB Presenters: Paul Cassidy,
Is it useful to control blood pressure faster in hypertensive patients? Based on: Gradman AH et al. Hypertension. 2013;61:
All Providers Meeting November 6,  Import Limited Surveillance Data into CAREWare for Clients Who Give Consent  HIV diagnosis date  AIDS diagnosis.
KZN STUDY –UPDATE South African ART Resistance Cohort Studies (SARCS)
L INKING AND R ETAINING HIV P OSITIVE I NDIVIDUALS IN M EDICAL AND S UPPORTIVE C ARE Katie Horstmann Wake County Human Services HIV/AIDS Case Management.
HIV in British Columbia: Recent Trends Presentation for the Pacific AIDS Network February 25, 2009 Stephen Smith Manager, Blood-borne Pathogens.
High rates of survival, virologic suppression and immune reconstitution among patients receiving second-line ART in the Indian national programme B.B.
Late HIV Diagnoses, Georgia,
HIV Care Continuum for the United States and Puerto Rico National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
The CDC Prevention Grant Funding Opportunity Announcement (FOA) and OA’s Response Overview and Discussion September 21, 2011 California Department of Public.
Integrating Evidence-Based Practice Into QI to Improve Patient Outcomes in HIV: Viral Load Suppression Victoria Lieb, ACRN, MPH; Carla Rossi, MD; Jaime.
Cost-effectiveness of different starting criteria of antiretroviral therapy in Mexico. Caro Y., Colchero A., Valencia A., Bautista-Arredondo S., Sierra.
HAART and Viral Load Comparison Report Tamarra Jones, DrPH, CHES Orange County Health Care Agency HIV Planning and Coordination Manager.
The Hotspotters Retention and VL Supression Monitoring Project Ivy Clinic, Arnot Ogden Medical Center DRAFT Quality Improvement Team  Clinical Coordinator.
2 About HIV: Teaching Tool. About HIV: A teaching tool © 2nd edition 2006 This tool was developed by the François-Xavier Bagnoud Center at the University.
Policies on Women Health Care. Policy on Breast Cancer Since 1994, a $23 billion investment in cancer research, the incidence of cancer is up 18 percent,
Outcome of 2009 Quality Management Site Visits. OAMC – Outpatient/Ambulatory Medical Care, MCM – Medical Case Management, SA – Substance Abuse Readiness,
Quality of Care at a Multi-site PEPFAR-funded ART Program: From Measuring to Improvement.
Nurses SOAR! Training Curricula Series For More Information and Inquiries:
eHARS to CAREWare Pilot Project Update and Training
HIV Care Continuum New Diagnoses, 2011, Fulton County, Georgia.
Treatment and scale up access TV, ART OST treatment for people who use drug sin SEA Ekta.
Annual Epidemiological Spotlight on HIV in London: 2014 data Field Epidemiology Services PHE Publications gateway number
MINNESOTA’S HIV TREATMENT CASCADE April, Introduction.
HIVQUAL – ARV Management October 17, 2003 Saneese Stephen, RPA Kings County Hospital Center Center for H.O.P.E.
1 Adherence to ARV Therapy and Resistance HAIVN Havard Medical School AIDS Initiative in Vietnam.
Strategies for Management of Antiretroviral Therapy Study Wafaa El-Sadr and James Neaton for the SMART Study Team.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Figure 2: Trends in currently prescribed antiretroviral therapy % prescribed HAART increased from 74% to 83% Trends in ART use, HIV viral load, and CD4.
From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.
MASIVUKENI: A Multimedia ART Initiation and Adherence Intervention for Resource-Limited Settings Robert H. Remien, Claude A. Mellins, Reuben Robbins, Hetta.
HRSA Talk: HIV From the Inside USCA 2016 – September 17, 2016 Harold Phillips, Director Office of Domestic & Global HIV Training & Capacity Development.
Learning objectives Review HIV treatment goals
HIV Care Continuum Ryan White Program - Miami-Dade County
Title Factors associated with viral suppression among adolescents living with HIV in Cambodia “No conflicts of interest to declare”
CIIS Implementation in Progress Mari-Lynn Drainoni, PhD, MEd
Validating Definitions of Antiretroviral Treatment Failure in Malawi
Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
VL patient support: General education at different levels
2nd line treatment counseling for adult patients
Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana ¹Obiri-Yeboah Dorcas, School of Medical Sciences,
HIV Quality Improvement (QI) and the Treatment Cascade: How QI has Impacted Reach, Recruitment, Testing, Treatment, and Retention Efforts in Thailand?
Is Your Patient Engaged in Care
In+Care 04 – Viral Load Suppression Project
State Office of AIDS Update
Our Strategies for Viral Load Suppression
HIV Cross-Part Care Continuum Collaborative (H4C)
Carolina Family Health Centers In+care 04-Viral Load Suppression
Quality Improvement Team
Core Medical Services Waiver
EAC for children.
The 7th EAHSC Pharmacy refill counts and self-reported adherence overestimate adherence to antiretroviral treatment among people living with HIV in Kilimanjaro,
In+care 04: Viral Load Suppression Factors Influencing Data
Stakeholder engagement and research utilization: Insights from Namibia
Presentation transcript:

Quality Improvement Team In+Care - Improving Viral Load Suppression A Quality Improvement Project AIDS Activities Office Quality Improvement Team Carlos Castillo, RN Roselen Villalba, RN Lynn Nagel, BSEd, CQI Coordinator Stephen D Sabo, AA, Data Coordinator Length of study: February 2012 – January 2013 Focus on clients in the AAO Adherence Program

Background Information/Rationale for QI Project Clients missing doses of medication can lead to resistance Lowering of one’s viral load shows responding to treatment and following medication regiment Clients in the adherence education program will show a increase in viral load suppression. Overall in 2007, 64% of AAO clients had a suppressed viral load. In 2011, the percentage was 74.

Performance Measure In+Care 4: Percentage of clients with HIV infection whose last viral load in the measurement year is less than 200 copies

In Care -Baseline Data VL Suppression – Below 200 All AAO clients Year 2011 – 528/711 = 74% Clients in Adherence program Year 2011 – 118/194 = 60% Clients in adherence program November 1, 2011 – January 31, 2012 = 84 clients were enrolled in the adherence program. 56% (47/84) had a viral load of <200 Clients are referred to adherence program by physicians

Cause Diagram

PDSA – Plan/Do (First Quarter) Create flow diagram and review adherence process Create cause diagram and review with team Classification of clients in program, long term / short term Frequent adherence appointments will be scheduled as needed Frequent follow up phone calls Review list of clients on adherence & remove those that no longer need to be in program, lost to follow-up, moved, etc and removed these clients from active list Run monthly reports with VL’s for adherence nurses to monitor Interventions specific to individual clients needs that are in the Adherence Program Will help pay co-pays for clients Provide transportation assistance – bus passes or taxi vouchers

PSDA - Study/Results (First Quarter) All AAO clients Overall there was an increase in the number of clients with a viral load <200 to 77% (510/727) – April 30, 2012 For 2011 74%(528/711) of clients had a viral load <200 Incentives and perseverance on part of the adherence nurses have shown an increase in the number of clients with a viral load <200.

PSDA - Study/Results (First Quarter) Clients in Adherence Program – Feb 1 – April 30, 2012 92 clients were enrolled in the adherence program. 62% (57/92) had a viral load of <200 10 clients received transportation vouchers. 60% (6/10) had a viral load of <200 23 clients received co-pay assistance. 61% (14/23) had a viral load of <200 2 clients received both transportation & co-pay assistance. 0% (0/2) had a viral load of <200 57 clients did not receive any incentives. 61% (35/57) had a viral load of <200

PSDA - Study/Results (First Quarter) Months in Program VL <200 New – 2 months 23% (21/92) 3 months – 5 months 24% (22/92) > 6 months 15% (14/92) VL > 200 New – 2 months 20% (18/92) 3 months – 5 months 11% (10/92) > 6 months 8% (7/92)

PDSA – Act (Second Quarter) Next step: continue with paying co-pays, transportation needs, frequent visits & phone calls Design a bulletin board for visual reinforcement in the clinic on the importance of medication adherence Closely monitor “long term” clients for any adherence issues Compare 3 month data with 6 month data looking for trends